Latest Capital Raising And Funding News

Nanollose has successfully placed the $1.05 million shortfall from its recent entitlement offer, bolstering its capital to advance production and commercialisation of its innovative biomaterials.

Midas Minerals has locked in $6.5 million through a two-tranche placement to fund its strategic acquisition and exploration of the Otavi Copper Project in Namibia, alongside advancing its broader project portfolio.

Noxopharm Limited has raised nearly $2.5 million by selling its entire stake in Nyrada Inc, providing non-dilutive capital to advance its HERACLES clinical trial and expand its research pipeline.

Bass Limited’s May 2025 AGM update highlights a strategic acquisition and capital raising to accelerate its emergence as a key Australian gas producer, focusing on Cooper Basin and Indonesian assets.

Bass Oil Limited has acquired the Vanessa gas field from Beach Energy, marking its entry into gas production in Australia’s Cooper Basin. The company is raising $3.1 million to fund this acquisition alongside other growth initiatives.

DTI Group Ltd has announced a fully underwritten non-renounceable entitlement offer to raise approximately $2.69 million by issuing new shares at a discounted price of $0.006 each. The offer, backed by major shareholder Finico Pty Ltd, aims to strengthen the company’s balance sheet and repay existing debt.

Bio-Gene Technology Limited has launched a Share Purchase Plan allowing Australian shareholders to invest up to $15,000 at 2.3 cents per share, matching a recent $2.1 million placement. The offer includes free-attaching options, subject to shareholder approval, to support key product development milestones.

Metgasco Ltd has announced a partially underwritten entitlement offer to raise up to $750,000, aiming to fund a production uplift program at its Odin and Vali gas fields. The capital raise targets near-term gas flow improvements and enhanced cash generation.

Adelong Gold has locked in a binding agreement to acquire the Lauriston Gold Project, boasting exceptional high-grade gold mineralisation adjacent to the world-class Fosterville Mine. The acquisition, backed by a $3 million capital raise, positions Adelong to rapidly expand its Victorian gold portfolio.

Askari Metals has reported a significant 28% increase in its Burracoppin Gold Project resource, while advancing strategic acquisitions in Africa and completing a $1.1 million capital raise.

Recce Pharmaceuticals reports strong Phase II clinical trial results for its topical anti-infective R327G, achieving a 93% efficacy rate in treating ABSSSI, alongside a significant capital raise to fund upcoming Phase III trials.

Equinox Resources pushes forward across multiple mineral projects, tackling legal challenges at Hamersley while securing strategic partnerships for antimony supply and expanding exploration in Brazil and Canada.